TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 7, 2023 at 3:00 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investorsā section and the "Events and Presentations" tab, or by using the following link:
https://ir.prestigebrands.com/events-presentations/events
For those unable to participate during the live webcast, a replay option will be available on the Companyās website following the event.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is a leading consumer healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Companyās diverse and iconic portfolio of brands include MonistatĀ® and Summerās EveĀ® women's health products, BCĀ® and Goody'sĀ® pain relievers, Clear EyesĀ® and TheraTearsĀ® eye care products, DenTekĀ® specialty oral care products, DramamineĀ® motion sickness treatments, FleetĀ® enemas and glycerin suppositories, ChlorasepticĀ® and Luden'sĀ® sore throat treatments and drops, Compound WĀ® wart treatments, Little RemediesĀ® pediatric over-the-counter products, Boudreauxās Butt PasteĀ® diaper rash ointments, NixĀ® lice treatment, DebroxĀ® earwax remover, GavisconĀ® antacid in Canada, and HydralyteĀ® rehydration products and the FessĀ® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
